Open AccessHigh Frequency of Tc22 and Th22 Cells in Myasthenia Gravis Patients and Their Significant Reduction after Thymectomy
Author(s) -
Behrouz Robat-Jazi,
Mina Hosseini,
Vahid Shaygannejad,
Shahriar Nafissi,
Abbas Rezaei,
Marjan Mansourain,
Omid Mirmosayyeb,
Nafiseh Esmaeil
Publication year - 2018
Publication title -
neuroimmunomodulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.635
H-Index - 65
eISSN - 1423-0216
pISSN - 1021-7401
DOI - 10.1159/000490855
Subject(s) - myasthenia gravis , thymectomy , pathogenesis , medicine , gastroenterology , autoimmune disease , disease , endocrinology
Myasthenia gravis (MG) is an autoimmune disease accompanied by a thymic pathology and in most patients thymectomy (TE) is used as the therapeutic approach. Both B and T cells play an important role in MG pathogenesis.